A new antiviral drug heading into clinical trials offers hope for COVID-19 treatment
Scientists are hopeful that a new drug—called EIDD-2801—could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.
Apr 6, 2020
0
3305